These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 650326)

  • 1. Indomethacin in the treatment of idiopathic minimal lesion nephrotic syndrome.
    Garin EH; Williams RL; Fennell RS; Richard GA
    J Pediatr; 1978 Jul; 93(1):138-40. PubMed ID: 650326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of the nephrotic syndrome with indomethacin.
    Donker AJ; Brentjens JR; van der Hem GK; Arisz L
    Nephron; 1978; 22(4-6):374-81. PubMed ID: 740100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of proteinuria by indomethacin in patients with nephrotic syndrome.
    Alavi N; Lianos EA; Venuto RC; Mookerjee BK; Bentzel CJ
    Am J Kidney Dis; 1986 Dec; 8(6):397-403. PubMed ID: 3468803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapy.
    Espinoza LR; Jara LJ; Martinez-Osuna P; Silveira LH; Cuellar ML; Seleznick M
    Lupus; 1993 Feb; 2(1):9-14. PubMed ID: 8485564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine and other therapy-resistant nephrotic syndrome.
    van Hooff JP; Leunissen KM; Havenith MG; Bosman FT
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):293-6. PubMed ID: 3381286
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome.
    Pennisi AJ; Grushkin CM; Lieberman E
    Pediatrics; 1976 Jun; 57(6):948-51. PubMed ID: 934751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indomethacin on proteinuria in rats with autologous immune complex nephropathy.
    Kirschenbaum MA; Liebross BA; Serros ER
    Prostaglandins; 1985 Aug; 30(2):295-303. PubMed ID: 2931744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin and the nephrotic syndrome.
    Shehadeh IH; Demers LM; Abt AB; Schoolwerth AC
    JAMA; 1979 Mar; 241(12):1264-6. PubMed ID: 762792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indomethacin in the therapy of prolonged or chronic glomerulonephritis and of the nephrotic syndrome].
    Campanacci L; Gambari P; Castellani A; Huber W
    Clin Ter; 1972 Apr; 61(1):31-46. PubMed ID: 5039599
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiproteinuric effect of naproxen and indomethacin. A double-blind crossover study.
    Vriesendorp R; Donker AJ; de Zeeuw D; de Jong PE; van der Hem GK
    Am J Nephrol; 1985; 5(4):236-42. PubMed ID: 3901756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome.
    Arisz L; Donker AJ; Brentjens JR; van der Hem GK
    Acta Med Scand; 1976; 199(1-2):121-5. PubMed ID: 1251764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.
    Garini G; Mazzi A; Buzio C; Mutti A; Allegri L; Savazzi G; Borghetti A
    Nephrol Dial Transplant; 1996 Apr; 11(4):628-34. PubMed ID: 8671850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indomethacin in the treatment of the nephrotic syndrome and residuaproteinuria].
    Murisasco A; Picon G; Hebreard J; Sansot M; Aubert L; Taramasco J; Mrtin J; Manassero L
    Mars Med; 1967; 104(9):787-91. PubMed ID: 5619524
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteinuria and fusion of podocyte foot processes in rats after infusion of cytokine from patients with idiopathic minimal lesion nephrotic syndrome.
    Garin EH; Laflam PF; Muffly K
    Nephron Exp Nephrol; 2006; 102(3-4):e105-12. PubMed ID: 16330882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.
    Vriesendorp R; de Zeeuw D; de Jong PE; Donker AJ; Pratt JJ; van der Hem GK
    Clin Nephrol; 1986 Feb; 25(2):105-10. PubMed ID: 3516475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the use of indomethacin in the treatment of renal diseases in childhood].
    Varese LA; Antoniola P
    Minerva Pediatr; 1970 Jul; 22(28):1440-3. PubMed ID: 5515768
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin.
    Pomeranz A; Wolach B; Bernheim J; Korzets Z; Bernheim J
    J Pediatr; 1995 Jan; 126(1):140-2. PubMed ID: 7815205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic nephrotic syndrome. Effect of oral cromoglycate].
    Laurent J; André C; Rostocker G; Lagrue G
    Presse Med; 1990 May; 19(20):950-2. PubMed ID: 2141132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of captopril treatment in children with steroid-resistant nephrotic syndrome.
    Sözüer DT; Emre S; Tanman F; Sirin A; Nayir A; Uysal V
    Acta Paediatr Jpn; 1994 Dec; 36(6):658-61. PubMed ID: 7871977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S; Surapaitoolkorn W; Tancharoen W; Pattaragarn A; Sumboonnanonda A
    Pediatr Int; 2012 Dec; 54(6):793-7. PubMed ID: 22621380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.